Vice President, Drug Safety
Iovance Biotherapeutics develops T-cell-based immunotherapy products for the treatment of cancer.
Director, DSPH Risk Management at Gilead Sciences, Inc.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Marcus Littman at Iovance Biotherapeutics then you've come to the right place.
Wondering if it's marcus@iovance.com, marcus.littman@iovance.com, littman@iovance.com, or mlittman@iovance.com? We have the answers for you.